Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,250,000 | 6,035,000 | 5,552,000 | 5,801,000 | 6,106,000 |
| Marketable Securities | N/A | N/A | 2,567,000 | N/A | N/A |
| Receivables | 10,792,000 | 10,484,000 | 10,051,000 | 10,519,000 | 10,487,000 |
| Inventories | 7,263,000 | 7,021,000 | 6,744,000 | 6,845,000 | 6,420,000 |
| Other current assets | 3,540,000 | 3,255,000 | 3,090,000 | 2,983,000 | 3,109,000 |
| TOTAL | $26,845,000 | $26,795,000 | $28,004,000 | $26,148,000 | $26,122,000 |
| Non-Current Assets | |||||
| PPE Net | 16,832,000 | 16,585,000 | 16,939,000 | 16,182,000 | 15,584,000 |
| Investments And Advances | 0 | 0 | 9,957,000 | 0 | 0 |
| Intangibles | 59,983,000 | 60,485,000 | 61,421,000 | 61,924,000 | 60,566,000 |
| Other Non-Current Assets | 17,412,000 | 17,146,000 | 7,870,000 | 16,965,000 | 16,220,000 |
| TOTAL | $94,227,000 | $94,216,000 | $96,187,000 | $95,071,000 | $92,370,000 |
| Total Assets | $121,072,000 | $121,011,000 | $124,191,000 | $121,219,000 | $118,492,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,256,000 | 9,334,000 | 5,945,000 | 5,017,000 | 8,878,000 |
| Accounts payable and accrued liabilities | 5,042,000 | 4,875,000 | 5,593,000 | 4,591,000 | 4,585,000 |
| Other current liabilities | 12,090,000 | 12,160,000 | 10,443,000 | 12,251,000 | 11,457,000 |
| TOTAL | $24,388,000 | $26,369,000 | $24,051,000 | $21,859,000 | $24,920,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,615,000 | 11,610,000 | 13,781,000 | 15,823,000 | 13,754,000 |
| Other Non-Current Liabilities | 15,409,000 | 15,860,000 | 9,773,000 | 16,305,000 | 15,550,000 |
| TOTAL | $27,056,000 | $27,494,000 | $30,877,000 | $32,155,000 | $29,331,000 |
| Total Liabilities | $51,444,000 | $53,863,000 | $54,928,000 | $54,014,000 | $54,251,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 1,001,000 | N/A | N/A |
| Retained earnings | N/A | N/A | 68,228,000 | N/A | N/A |
| Other shareholders' equity | 69,628,000 | 67,148,000 | 126,000 | 67,205,000 | 64,241,000 |
| TOTAL | $69,628,000 | $67,148,000 | $69,263,000 | $67,205,000 | $64,241,000 |
| Total Liabilities And Equity | $121,072,000 | $121,011,000 | $124,191,000 | $121,219,000 | $118,492,000 |